0001225208-17-007698.txt : 20170405 0001225208-17-007698.hdr.sgml : 20170405 20170405212703 ACCESSION NUMBER: 0001225208-17-007698 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170405 FILED AS OF DATE: 20170405 DATE AS OF CHANGE: 20170405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOBO DONALD E JR CENTRAL INDEX KEY: 0001196661 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 17744291 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 4 1 doc4.xml X0306 4 2017-04-05 0001099800 Edwards Lifesciences Corp EW 0001196661 BOBO DONALD E JR ONE EDWARDS WAY IRVINE CA 92614 1 CVP, Heart Valve Therapy Common Stock 2017-04-05 4 M 0 18720.0000 25.4800 A 85814.6555 D Common Stock 2017-04-05 4 S 0 200.0000 94.4300 D 85614.6555 D Common Stock 2017-04-05 4 S 0 13520.0000 93.5691 D 72094.6555 D Common Stock 12430.6829 I 401(k) Common Stock 9604.0000 I By Trust Employee Stock Option (Right to Acquire) 25.4800 2017-04-05 4 M 0 18720.0000 0.0000 D 2011-05-13 2017-05-12 Common Stock 18720.0000 18720.0000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator. This transaction was executed in multiple trades at prices ranging from $93.02 to $93.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Shares represented on the most recent statement of Issuer's 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equity to share equivalents. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Ifigenia Protopappas, Attorney-in-fact 2017-04-05